821. In HF with secondary mitral regurgitation, transcatheter mitral valve repair reduced HF hospitalizations at 5 y.
Stone GW, Abraham WT, Lindenfeld J, et al; COAPT Investigators. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med. 2023;388:2037-2048. 36876756.
822. In moderately to severely active UC, etrasimod increased remission at 12 and 52 wk but increased adverse events.
Sandborn WJ, Vermeire S, Peyrin-Biroulet L, et al. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Lancet. 2023;401:1159-1171. 36871574.
823. In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome at 1 y.
Diletti R, den Dekker WK, Bennett J, et al; BIOVASC Investigators. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023;401:1172-1182. 36889333.
824. In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y.
Huss V, Bower H, Hellgren K, et al; ARTIS group. Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study. Ann Rheum Dis. 2023;82:911-919. 36868796.
825. In adults at CV risk, Mediterranean-style or low-fat dietary programs vs. minimal interventions reduce all-cause mortality.
Karam G, Agarwal A, Sadeghirad B, et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ. 2023;380:e072003. 36990505.
826. Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV.
作者: Monica Gandhi.;Matthew Hickey.;Elizabeth Imbert.;Janet Grochowski.;Francis Mayorga-Munoz.;John D Szumowski.;Jon Oskarsson.;Mary Shiels.;John Sauceda.;Jorge Salazar.;Samantha Dilworth.;Janet Q Nguyen.;David V Glidden.;Diane V Havlir.;Katerina A Christopoulos.
来源: Ann Intern Med. 2023年176卷7期969-974页
Intramuscular cabotegravir (CAB) and rilpivirine (RPV) is the only long-acting antiretroviral therapy (LA-ART) regimen approved for people with HIV (PWH). Long-acting ART holds promise for improving outcomes among populations with barriers to adherence but is only approved for PWH who have virologic suppression with use of oral ART before initiating injectables.
827. In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 mo.
Nissen SE, Lincoff MA, Brennan D, et al; CLEAR Outcomes Investigators. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388:1353-1364. 36876740.
828. In type 1 diabetes, weekly basal insulin Fc was noninferior to daily insulin degludec for HbA1c at 26 wk.
Kazda CM, Bue-Valleskey JM, Chien J, et al. Novel once-weekly basal insulin Fc achieved similar glycemic control with a safety profile comparable to insulin degludec in patients with type 1 diabetes. Diabetes Care. 2023;46:1052-1059. 36920867.
829. In ischemic stroke, adding EVT to usual care at 6 to 24 h improved functional status at 90 d.
Olthuis SGH, Pirson FAV, Pinckaers FME, et al; MR CLEAN-LATE investigators. Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial. Lancet. 2023;401:1371-1380. 37003289.
830. In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome.
Hong SJ, Lee YJ, Lee SJ, et al; LODESTAR Investigators. Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial. JAMA. 2023;329:1078-1087. 36877807.
831. Effects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain.
作者: Emma E McGinty.;Kayla N Tormohlen.;Nicholas J Seewald.;Mark C Bicket.;Alexander D McCourt.;Lainie Rutkow.;Sarah A White.;Elizabeth A Stuart.
来源: Ann Intern Med. 2023年176卷7期904-912页
State medical cannabis laws may lead patients with chronic noncancer pain to substitute cannabis in place of prescription opioid or clinical guideline-concordant nonopioid prescription pain medications or procedures.
832. Performance of Rapid Antigen Tests to Detect Symptomatic and Asymptomatic SARS-CoV-2 Infection : A Prospective Cohort Study.
作者: Apurv Soni.;Carly Herbert.;Honghuang Lin.;Yi Yan.;Caitlin Pretz.;Pamela Stamegna.;Biqi Wang.;Taylor Orwig.;Colton Wright.;Seanan Tarrant.;Stephanie Behar.;Thejas Suvarna.;Summer Schrader.;Emma Harman.;Chris Nowak.;Vik Kheterpal.;Lokinendi V Rao.;Lisa Cashman.;Elizabeth Orvek.;Didem Ayturk.;Laura Gibson.;Adrian Zai.;Steven Wong.;Peter Lazar.;Ziyue Wang.;Andreas Filippaios.;Bruce Barton.;Chad J Achenbach.;Robert L Murphy.;Matthew L Robinson.;Yukari C Manabe.;Shishir Pandey.;Andres Colubri.;Laurel O'Connor.;Stephenie C Lemon.;Nisha Fahey.;Katherine L Luzuriaga.;Nathaniel Hafer.;Kristian Roth.;Toby Lowe.;Timothy Stenzel.;William Heetderks.;John Broach.;David D McManus.
来源: Ann Intern Med. 2023年176卷7期975-982页
The performance of rapid antigen tests (Ag-RDTs) for screening asymptomatic and symptomatic persons for SARS-CoV-2 is not well established.
833. Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population : A Randomized Controlled Trial.
作者: Shuhao Lin.;Sofia Cienfuegos.;Mark Ezpeleta.;Kelsey Gabel.;Vasiliki Pavlou.;Andrea Mulas.;Kaitie Chakos.;Mara McStay.;Jackie Wu.;Lisa Tussing-Humphreys.;Shaina J Alexandria.;Julienne Sanchez.;Terry Unterman.;Krista A Varady.
来源: Ann Intern Med. 2023年176卷7期885-895页
Time-restricted eating (TRE), without calorie counting, has become a popular weight loss strategy, yet long-term randomized trials evaluating its efficacy are limited.
834. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
作者: Faizan Khan.;Doug Coyle.;Kednapa Thavorn.;Sasha van Katwyk.;Tobias Tritschler.;Brian Hutton.;Grégoire Le Gal.;Marc A Rodger.;Dean A Fergusson.
来源: Ann Intern Med. 2023年176卷7期949-960页
Clinical practice guidelines recommend indefinite anticoagulation for a first unprovoked venous thromboembolism (VTE).
835. Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 × 2 Factorial Trial.
作者: Xiao-Ke Wu.;Jing-Shu Gao.;Hong-Li Ma.;Yu Wang.;Bei Zhang.;Zhao-Lan Liu.;Jian Li.;Jing Cong.;Hui-Chao Qin.;Xin-Ming Yang.;Qi Wu.;Xiao-Yong Chen.;Zong-Lin Lu.;Ya-Hong Feng.;Xue Qi.;Yan-Xiang Wang.;Lan Yu.;Ying-Mei Cui.;Chun-Mei An.;Li-Li Zhou.;Yu-Hong Hu.;Lu Li.;Yi-Juan Cao.;Ying Yan.;Li Liu.;Yu-Xiu Liu.;Zhi-Shun Liu.;Rebecca C Painter.;Ernest H Y Ng.;Jian-Ping Liu.;Ben Willem J Mol.;Chi Chiu Wang.
来源: Ann Intern Med. 2023年176卷7期922-933页
An effective and safe treatment for nausea and vomiting of pregnancy (NVP) is lacking.
836. Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.
作者: Zoe K McQuilten.;Le Thi Phuong Thao.;Sant-Rayn Pasricha.;Andrew S Artz.;Michael Bailey.;Andrew T Chan.;Harvey Jay Cohen.;Jessica E Lockery.;Anne M Murray.;Mark R Nelson.;Hans G Schneider.;Rory Wolfe.;Robyn L Woods.;Erica M Wood.;John J McNeil.
来源: Ann Intern Med. 2023年176卷7期913-921页
Daily low-dose aspirin increases major bleeding; however, few studies have investigated its effect on iron deficiency and anemia.
837. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue : A GeoSentinel Analysis.
作者: Ralph Huits.;Kristina M Angelo.;Bhawana Amatya.;Sapha Barkati.;Elizabeth D Barnett.;Emmanuel Bottieau.;Hannah Emetulu.;Loïc Epelboin.;Gilles Eperon.;Line Medebb.;Federico Gobbi.;Martin P Grobusch.;Oula Itani.;Sabine Jordan.;Paul Kelly.;Karin Leder.;Marta Díaz-Menéndez.;Nobumasa Okumura.;Aisha Rizwan.;Camilla Rothe.;Mauro Saio.;Jesse Waggoner.;Yukihiro Yoshimura.;Michael Libman.;Davidson H Hamer.;Eli Schwartz.
来源: Ann Intern Med. 2023年176卷7期940-948页
Dengue virus is a flavivirus transmitted by Aedes mosquitoes and is an important cause of illness worldwide. Data on the severity of travel-associated dengue illness are limited.
838. How Would You Manage This Patient With Recurrent Diverticulitis? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
作者: Howard Libman.;Judy W Nee.;Anthony J Lembo.;Risa B Burns.
来源: Ann Intern Med. 2023年176卷6期836-843页
Acute diverticulitis, which refers to inflammation or infection, or both, of a colonic diverticulum, is a common medical condition that may occur repeatedly in some persons. It most often manifests with left-sided abdominal pain, which may be associated with low-grade fever and other gastrointestinal symptoms. Complications may include abscess, fistula formation, perforation, and bowel obstruction. The American College of Physicians recently published practice guidelines on the diagnosis and management of acute diverticulitis, the role of colonoscopy after resolution, and interventions to prevent recurrence of this condition. Among the recommendations were the use of abdominal computed tomography (CT) scanning in cases where there was diagnostic uncertainty, initial management of uncomplicated cases in the outpatient setting without antibiotics, referral for colonoscopy after an initial episode if not performed recently, and discussion of elective surgery to prevent recurrent disease in patients with complicated diverticulitis or frequent episodes of uncomplicated disease. Here, 2 gastroenterologists with expertise in acute diverticulitis debate CT scanning for diagnosis, antibiotics for treatment, colonoscopy to screen for underlying malignancy, and elective surgery to prevent recurrent disease.
839. Dyslipidemia.
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
840. In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease.
Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.
|